Sabby Management’s Rosetta Genomics Ltd. ROSG Stock Holding History

Sabby Management’s Portfolio ROSG Stock Details ROSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-941,693	Closed	-$19K	–	161
2018 Q2	$19K	Buy	941,693 +7,085	+0.8%	+$2.86K	﹤0.01%	130
2018 Q1	$383K	Buy	+934,608	New	+$453K	0.05%	104
2017 Q4	–	Sell	-141,741	Closed	-$149K	–	222
2017 Q3	$149K	Buy	+141,741	New	+$251K	0.01%	132
2017 Q1	–	Sell	-49,278	Closed	-$248K	–	364
2016 Q4	$248K	Buy	+49,278	New	+$377K	0.01%	234
2016 Q1	–	Sell	-13,246	Closed	-$196K	–	392
2015 Q4	$196K	Buy	+13,246	New	+$286K	0.01%	284

Sabby Management's ROSG Position: Q3 2018 in Review

Sabby Management sold out of Rosetta Genomics Ltd. (ROSG) in Q3 2018, closing a stake of 941,693 shares — an estimated $19K sold.

Sabby Management first reported a position in ROSG in Q4 2015 and held it in 5 quarters. The position peaked at $383K in Q1 2018. 1 fund tracked by Wall St. Rank holds ROSG as of Q3 2018.

Sabby Management reported no remaining Rosetta Genomics Ltd. position as of Q3 2018 after selling out during the quarter.
Sabby Management sold 941,693 Rosetta Genomics Ltd. shares in Q3 2018, an estimated $19K.
Sabby Management first reported a position in Rosetta Genomics Ltd. in Q4 2015 and held it in 5 quarters.
Sabby Management's Rosetta Genomics Ltd. position peaked at $383K in Q1 2018.
1 fund tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q3 2018.

Based on Sabby Management's 13F filing for Q3 2018, filed 14 Nov 2018.